US Patent Issued to REGENERON PHARMACEUTICALS on April 22 for "Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof" (New York, Delaware Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,124, issued on April 22, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof" was invented by Amy Han (Hockessin, Del.), Haruka Okamoto (New York) and William Olson (Yorktown Heights, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are protein-drug conjugates and compositions thereof that are useful, for example, for targeting glucagon-like peptide 1 receptor (GLP1R). In certain embodiments, provided are peptidomimetic payloads and linker-payloads and methods of making same. More specifically, GLP1 peptidomimetics, antibody-drug conjugates, a...